Gene expression profiling predicts clinical outcome of breast cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature

• Publication date

  2002-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/415530aPMID 11823860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclins and breast cancer

  2004cited by this paper
• Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

  2002cited by this paper
• Meeting highlights: International Consensus Panel on the treatment of primary breast cancer.

  2002cited by this paper
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

  2002cited by this paper
• Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

  2001cited by this paper
• Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

  2001cited by this paper
• Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

  2001cited by this paper
• Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer

  2001cited by this paper
• BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

  2001cited by this paper
• Microarrays—the 21st century divining rod?

  2001cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.

  2000cited by this paper
• Linking gene expression patterns to therapeutic groups in breast cancer.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Molecular profiling of breast cancer: portraits but not physiognomy

  2000cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Cyclins and Breast Cancer

  1996cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cited by this paper
• Genetic alterations in breast cancer

  1995cited by this paper
• Breast cancer prognostic factors: evaluation guidelines.

  1991cited by this paper

• Nuevas fronteras en la oncología de precisión: la transcriptómica y la proteómica

  2026cites this paper
• An interpretable breast cancer risk stratification model via multi-omics integration: multi-method development and cross-cohort validation.

  2026cites this paper
• engGNN: A Dual-Graph Neural Network for Omics-Based Disease Classification and Feature Selection

  2026cites this paper
• A clinicopathological and spatial feature-based nomogram for individualized prediction of axillary lymph node involvement in breast cancer

  2026cites this paper
• Discovery of predictive biomarkers for cancer therapy through computational approaches

  2026cites this paper
• Deep Semi-Supervised Survival Analysis for Predicting Cancer Prognosis

  2026cites this paper
• Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis

  2026cites this paper
• KIF14 in cancer biology: implications for diagnosis and therapy

  2026cites this paper
• Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers

  2026influential citation
• Molecular and Immune Mechanisms Governing Cancer Metastasis, Including Dormancy, Microenvironmental Niches, and Tumor-Specific Programs

  2026cites this paper
• FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer.

  2026cites this paper
• Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.

  2026cites this paper
• New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication

  2026cites this paper
• Prediction of lung metastasis in breast cancer patients using machine learning classifiers.

  2025cites this paper
• Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer

  2025cites this paper
• Variable selection and estimation for high dimensional partially linear varying coefficient models with missing data and measurement errors based on quantile regression

  2025cites this paper
• Automating candidate gene prioritization with large language models: from naive scoring to literature-grounded validation

  2025cites this paper
• Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment

  2025cites this paper
• Subvisual imaging signals as biomarkers of impending lung metastasis: A multicenter pan-cancer study.

  2025cites this paper
• Deciphering the liver’s role in pancreatic cancer metastasis: pathways and therapeutic approaches

  2025cites this paper
• A valuable predictive model for optimizing the timing of oocyte retrieval: a retrospective analysis of oocyte retrieval time in 49,961 oocyte pickup (OPU) cycles

  2025cites this paper
• An Overview of Analytical Approaches to Cancer Proteogenomics.

  2025cites this paper
• The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis

  2025cites this paper
• Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma

  2025cites this paper
• Prognostic and Predictive Assays in Invasive Breast Carcinoma Beyond Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2.

  2025cites this paper
• Multi-gene expression assays in breast cancer: a literature review

  2025cites this paper
• Multi-omics strategies for biomarker discovery and application in personalized oncology

  2025cites this paper
• Copula Based Fusion of Clinical and Genomic Machine Learning Risk Scores for Breast Cancer Risk Stratification

  2025cites this paper
• AdhesionScore: A Prognostic Predictor of Breast Cancer Patients Based on a Cell Adhesion-Associated Gene Signature

  2025cites this paper
• Unsupervised Random Forest Identifies Important Genetic Prognostic Factors for Breast Cancer Survival Time

  2025cites this paper
• Multi-transcriptomics predicts clinical outcome in systemically untreated breast cancer patients with extensive follow-up

  2025cites this paper
• Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast Cancer.

  2025cites this paper
• Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised Transformer

  2025cites this paper
• Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes

  2025cites this paper
• Simulation comparison of the effects of missing data imputation methods on classification performance in high dimensional data

  2025cites this paper
• Lifetime analysis with monotonic degradation: a boosted first hitting time model based on a homogeneous gamma process

  2025cites this paper
• Identification and validation of autophagy-related genes in sepsis based on bioinformatics studies

  2025cites this paper
• Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer

  2025cites this paper
• An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes

  2025cites this paper
• Navigating Endocrine Sensitivity Assessment in Nonmetastatic Breast Cancer Through Early On-Treatment Ki67 Understanding.

  2025cites this paper
• Correlation of MammaPrint to Histopathologic Variables and Comparison to Magee Equations in Adjuvant and Neoadjuvant Cohorts of Estrogen-Receptor Positive HER2-Negative Breast Carcinoma

  2025cites this paper
• Pre-validation Revisited

  2025cites this paper
• Protein-Level Analysis of Differential Response to Chemotherapy in Triple-Negative Breast Cancer Identifies CYP1B1 as a Biomarker for Chemotherapy Resistance

  2025cites this paper
• A new filter based-instance selection for high dimensional data classification

  2025cites this paper
• Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies

  2025cites this paper
• Interfered feature elimination coupled with feature group selection for wound infection detection by electronic nose

  2025cites this paper
• Transcriptional patterns of cancer-related genes in primary and metastatic tumours revealed by machine learning

  2025cites this paper
• High-dimensional data classification: evaluating the impact of missing data imputation methods on performance

  2025cites this paper
• BPMambaMIL: A bio-inspired prototype-guided multiple instance learning for oncotype DX risk assessment in histopathology

  2025cites this paper
• Decoding the adaptive survival mechanisms of breast cancer dormancy

  2025cites this paper
• Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications

  2025cites this paper
• The pleiotropic roles of non-hormonal receptor basigin and regulatory microRNAs in breast cancer

  2025cites this paper
• A Deep Learning Pipeline for Epilepsy Genomic Analysis Using GPT-2 XL and NVIDIA H100

  2025cites this paper
• Personalized recurrence risk prediction in early-stage breast cancer through an integrative mathematical model based on MammaPrint®, radiotherapy, phenotype, and clinicopathological factors

  2025cites this paper
• Interpretable Machine Learning for Breast Cancer Biomarker Discovery: SHAP-Enhanced Analysis of Gene Expression and Sequence Patterns

  2025cites this paper
• A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer

  2025cites this paper
• Efficient encapsulation of a model drug in chitosan cathodic electrodeposition: Preliminary analysis using FTIR, UV-vis, and NMR spectroscopy.

  2025cites this paper
• Serine/threonine kinase 32 family proteins: The potential multifaceted regulators in cancer

  2025cites this paper
• AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from Histopathology

  2025cites this paper
• Cost-effectiveness analysis of gene-expression-based prognostic tests for patients with early-stage breast cancer in South Korea

  2025cites this paper
• A novel 9-gene classifier for predicting distant metastasis of soft-tissue sarcoma and multiple malignancies.

  2025cites this paper
• Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer.

  2025cites this paper
• A Comprehensive Review on Nanoparticles: Pivotal Element of Nanotechnology in Medicine and Healthcare System

  2025cites this paper
• Breast cancer prediction based on gene expression data using interpretable machine learning techniques

  2025cites this paper
• From gene modules to gene markers: an integrated AI-human approach selects CD38 to represent plasma cell-associated transcriptional signatures

  2025cites this paper
• Challenges and Opportunities for Statistics in the Era of Data Science

  2025cites this paper
• The Role of Molecular Profiling in De-Escalation of Toxic Therapy in Breast Cancer

  2025cites this paper
• A human metabolic map of pharmacological perturbations reveals drug modes of action

  2025cites this paper
• Integrating artificial intelligence and robotics for advancements in personalized medicine within life science

  2025cites this paper
• Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2− breast cancer

  2025cites this paper
• Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in Luminal Patients

  2025cites this paper
• ieGENES: A machine learning method for selecting differentially expressed genes in cancer studies

  2025cites this paper
• Adhesion strength of tumor cells predicts metastatic disease in vivo

  2025cites this paper
• Interpretable Multimodal Fusion Model for Bridged Histology and Genomics Survival Prediction in Pan‐Cancer

  2025cites this paper
• Epigenetic drivers of metalloproteinases and metastasis.

  2025cites this paper
• Tarone-Ware and peto-peto type weighted logrank tests as an alternative to the log-rank test for comparison of survival functions on right-censored data

  2025cites this paper
• Nomogram Development for Assessing Oncotype DX Recurrence Scores in Breast Cancer: A Chinese Population Study

  2025cites this paper
• Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A Review.

  2025cites this paper
• Single-cell and multi-omics integration reveals cholesterol biosynthesis as a synergistic target with HER2 in aggressive breast cancer

  2025cites this paper
• HybridGWOSPEA2ABC: a novel feature selection algorithm for gene expression data analysis and cancer classification.

  2025cites this paper
• Proteomics in Diagnostic Evaluation and Treatment of Breast Cancer: A Scoping Review

  2025cites this paper
• Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis

  2025cites this paper
• Mercury Bioaccumulation in Female Breast Cancer Is Associated to CXCR4 Expression

  2025cites this paper
• Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response

  2025cites this paper
• Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies

  2025cites this paper
• The impact of breast radiotherapy on the tumor genome and immune ecosystem.

  2025cites this paper
• Updates on Utility of Immunohistochemistry in Diagnosis of Metastatic Breast Cancer.

  2025cites this paper
• An ensemble classifier combining Dempster-Shafer theory and feature selection methods aggregation strategy

  2025cites this paper
• Prognostic Models for Breast Cancer: A Narrative Review.

  2025cites this paper
• An unlabelled data-driven sparse coding fusion framework for tumor classification

  2025cites this paper
• Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting

  2025cites this paper
• Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).

  2025cites this paper
• Pre treatment Neutrophil to Lymphocyte Ratio and Total Cholesterol Levels as Biomarkers for Breast Cancer

  2025cites this paper
• Unraveling prognostic factors in canine mammary gland tumors using machine learning

  2025cites this paper
• Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model

  2025cites this paper
• A Case‐Control Study on the Association Between MMP2 and MMP9 Genetic Polymorphisms and Breast Cancer

  2025cites this paper
• Programmable Nanodevice and Amplifier Module‐Based DNA Cascaded Logic Circuits for Breast Tumor Cell Subtype Discrimination

  2025cites this paper
• Capturing breast cancers’ copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond

  2025cites this paper
• A new optimization-based framework for enhanced feature selection with the Narwal optimizer

  2025cites this paper
• Exploring Flexible Penalization of Bayesian Survival Analysis Using Beta Process Prior for Baseline Hazard

  2025cites this paper